Core Points - Company signed a licensing agreement with Swiss Rockets AG to grant exclusive rights to its CoolMPS sequencing technology and general sequencing technology for commercialization outside the Asia-Pacific and Greater China regions [1][2] - The agreement allows Swiss Rockets to develop and commercialize CoolMPS products while the company and its subsidiary will provide technical support and product development [2][3] - The licensing deal is expected to generate at least $120 million in licensing fees, improving the company's profitability and cash flow while allowing it to focus on its core Standard MPS technology [3] Licensing Agreement Details - The licensing agreement includes exclusive rights to CoolMPS technology and non-exclusive rights to general sequencing technology for CoolMPS product applications [2] - The company retains all rights in the Asia-Pacific and Greater China markets, enabling it to concentrate resources on core technologies and markets [3] - The agreement is aligned with the company's strategic direction, allowing for the monetization of technology without additional R&D investment [3] Financial Implications - The licensing agreement is projected to provide significant immediate profits and stable long-term cash flow, enhancing the company's financial position [3] - The expected licensing fees of no less than $120 million will contribute to improved profitability and cash flow [3]